And this is what is bothering me so much. We hav
Post# of 36568
(Total Views: 328)
Posted On: 03/20/2020 11:38:16 AM
And this is what is bothering me so much. We have two sides here. We have one side that says, let's wait and see, because Generex is working on the Vaccine and it's just around the corner and it's just one big pop and you will see this stock take off. Problem is, we have heard this with a lot of other things concerning Generex over the last 4 - 5 months on other things before the Virus even came out.
The other side is, Generex is slow to just come out with anything. They miss timelines. They don't give out information on products. They say one thing and do the complete opposite. You never know what to expect.
This company is very frustrating, to say the least. A lot of bragging, but not much to show right now. 40 - 70 million in funding that we have yet to see that could run the products, the MSO, everything right now. Not a peep on any of it. S-1 for Generex, that we have not heard any update on. Not a peep.
Stock in reality is about at the same PPS level if you took the dividend out. We are no better off right now than we were before the dividend. We just have more shares.
All in all, Generex right now is failing to perform. It's not OTC, it's Generex. There are no bad actors anymore. It's only Generex. They can right this ship. They can produce information on their products, they can build confidence with their shareholders.
It's up to them.
The other side is, Generex is slow to just come out with anything. They miss timelines. They don't give out information on products. They say one thing and do the complete opposite. You never know what to expect.
This company is very frustrating, to say the least. A lot of bragging, but not much to show right now. 40 - 70 million in funding that we have yet to see that could run the products, the MSO, everything right now. Not a peep on any of it. S-1 for Generex, that we have not heard any update on. Not a peep.
Stock in reality is about at the same PPS level if you took the dividend out. We are no better off right now than we were before the dividend. We just have more shares.
All in all, Generex right now is failing to perform. It's not OTC, it's Generex. There are no bad actors anymore. It's only Generex. They can right this ship. They can produce information on their products, they can build confidence with their shareholders.
It's up to them.
(2)
(0)